| (a) Not later than the third business day after the
date of dispensing a biological product, the dispensing pharmacist
or the pharmacist's designee shall communicate to the prescribing
practitioner the specific product provided to the patient, including
the name of the product and the manufacturer or national drug code
number.
(b) The communication must be conveyed by making an
entry into an interoperable electronic medical records system or through
electronic prescribing technology or a pharmacy benefit management
system or a pharmacy record, which may include information submitted
for the payment of claims, that a pharmacist reasonably concludes
is electronically accessible by the prescribing practitioner. Otherwise,
the pharmacist or the pharmacist's designee shall communicate the
biological product dispensed to the prescribing practitioner, using
facsimile, telephone, electronic transmission, or other prevailing
means, provided that communication is not required if:
(1) there is no interchangeable biological product
approved by the United States Food and Drug Administration for the
product prescribed; or
(2) a refill prescription is not changed from the product
dispensed on the prior filling of the prescription.
|
